Aperçu et prévisions du marché mondial des dispositifs d'administration de vaccins jusqu'en 2031 - Analyse du marché et part de marché

Marché mondial des dispositifs d'administration de vaccins - Aperçu de l'industrie

Le marché mondial des dispositifs d'administration de vaccins connaît une croissance rapide, stimulé par l'importance croissante accordée à la vaccination en tant qu'élément crucial de la santé publique à l'échelle mondiale. Selon l'OMS, la couverture mondiale de la première dose du vaccin contre le VPH chez les filles est passée de 20 % en 2022 à 27 % en 2023. Cette croissance est en grande partie due à la poursuite des initiatives de vaccination contre diverses maladies infectieuses , notamment la grippe, la COVID-19 et d'autres maladies endémiques. Les améliorations technologiques des technologies d'administration des vaccins, telles que les dispositifs sans aiguille et auto-administrés, augmentent l'efficacité et le confort de la vaccination, contribuant ainsi à la croissance du marché.

Le rapport de recherche sur le marché de Data Bridge Market Research fournit des détails sur les nouveaux développements récents, la part de marché, les tendances du marché sur la base de ses segmentations et de son analyse régionale, l'impact des acteurs du marché, les analyses d'opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, l'analyse stratégique de la croissance du marché, la taille du marché, la croissance du marché des catégories, les niches d'application et la domination, les approbations de produits, les lancements de produits, les expansions géographiques, les innovations technologiques sur le marché. Pour obtenir plus d'informations sur le marché, contactez l'équipe d'analystes experts de Data Bridge Market Research. Notre équipe vous aidera à prendre des décisions de marché éclairées pour assurer la croissance de votre entreprise.

Taille du marché mondial des dispositifs d'administration de vaccins et analyse du marché

Enhanced public health campaigns are critical in increasing vaccination uptake and combatting vaccine hesitancy, and they play an important role in the expansion of the vaccine administration devices industry.  For instance, the "It's On Us" campaign, which was established during the COVID-19 pandemic, effectively addressed vaccine safety concerns and encouraged inoculation through social media, public service announcements, and community involvement. By effectively addressing vaccination reluctance and misinformation, such initiatives help to boost immunization coverage, thus generating demand for effective vaccine administration devices. As a result, Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Vaccine Administration Devices Market is increasing at a CAGR of 7.90%. Our detailed analysis forecasts that the market is valued at USD 3.9 billion in 2023 and is expected to grow upto USD 6.9 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.

Global Vaccine Administration Devices Market Dynamics

Global Vaccine Administration Devices Market Growth Drivers

Increased Alliance and immunization programs

The market is driven by increasing immunization programs, rapid increase in immunization initiatives and campaigns, and rising disease rates around the world. For instance, the GAVI Alliance and the Bill & Melinda Gates Foundation are actively participating in immunological campaigns, which should considerably boost the market for vaccination administration devices.

Rise in chronic diseases

The rise in chronic diseases, such as diabetes and heart disease, has led to greater awareness of the importance of vaccination in at-risk populations. The World Health Organization (WHO) estimates that NCDs kill 41 million people each year, which is 74% of all deaths globally. The main types of NCDs are cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. Patients with chronic conditions often require vaccines that prevent complications from diseases, driving the need for reliable and easy-to-use vaccine administration devices.

Global Vaccine Administration Devices Market Growth Opportunities

Expansion in Emerging Markets

Expansion in emerging markets is significantly impacting the vaccine administration devices sector, driven by the growing healthcare infrastructure and vaccination programs. For instance, India administered over 2 billion doses of vaccines in mid-2022. As Developing regions enhance their healthcare systems and vaccination efforts, there is a rising demand for innovative administration devices to manage the increased vaccine distribution.

Innovation delivering progressive technologies

The vaccine administration devices market is undergoing considerable transformation due to technological breakthroughs such as needle-free injectors and auto-disable syringes. For instance, the Biojector 2000, a needle-free injector, has been successfully utilized in vaccination campaigns for diseases such as influenza and measles, providing a painless alternative that lowers the chance of needle-stick injuries. Such developments not only increase the safety and efficiency of vaccine delivery, but also address major public health concerns, making them critical for the Global Vaccine Administration Devices Market growth.

Global Vaccine Administration Devices Market Growth Challenges

Environmental concerns

The disposal of single-use vaccine administration devices, such as syringes and vials, adds to medical waste and poses environmental and public health risks. According to the World Health Organization (WHO), around 16 billion injections are provided globally each year. The need for sustainable solutions continues to rise, but providing eco-friendly alternatives without sacrificing safety or increasing costs is a challenge for manufacturers. Consequently hampering Global Vaccine Administration Devices Market Growth. 

Differing prices

The high expense of sophisticated vaccine delivery technologies, such as needle-free injectors and auto-disable syringes, poses a unique barrier to their general adoption, particularly in low- and middle-income countries. For instance, needle-free injectors such as PharmaJet's Tropis witness drastic price variation which makes them difficult to afford for large-scale vaccination campaigns in areas with limited healthcare resources.

Global Vaccine Administration Devices Market Growth Restraints

Regulatory hurdles

Regulatory challenges have a substantial impact on the worldwide vaccine administration devices market, as they provide barriers to the timely approval and launch of new technologies. For instance, Indian Central Drugs Standard Control Organization (CDSCO) demands extensive data and local testing before issuing approval, which adds time and cost for firms looking to access this large market.

Global Vaccine Administration Devices Market Scope and Trends

• Innovations Such as 3M’s Smart Syringe incorporate electronic components to track and record injection data, such as dose administration and timing. This technology aims to improve the accuracy of vaccine delivery and enhance patient safety.
• The ICMR and Panacea Biotec have launched India's first phase three clinical trial to produce a dengue vaccine. Panacea Biotec produced DengiAll, India's indigenous tetravalent dengue vaccine, and the first trial participant was vaccinated at the Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences in Rohtak.
• Iran received a substantial shipment of 564,000 doses of Pneumococcal Conjugate Vaccine (PCV), supported by UNICEF. This significant delivery is part of a broader initiative to enhance the country's immunization efforts and improve public health outcomes.
• Vietnam's routine immunization program received a significant boost with the arrival of 490,600 doses of the DTP-HepB-Hib vaccine, provided by Australia in partnership with UNICEF. This crucial shipment supports Vietnam's ongoing efforts to enhance its vaccination coverage and protect children against a range of preventable diseases.

Global Vaccine Administration Devices Market Regional Analysis – Market Trends

Key Insights

• North America's substantial investment in vaccine R&D and public health initiatives supports market expansion. The U.S. and Canada, is a leading market for vaccine administration devices, driven by high healthcare expenditure and advanced medical infrastructure.
• En Europe, le marché des dispositifs d’administration de vaccins est considérable, alimenté par des systèmes de santé bien établis et des cadres réglementaires favorables. L’UE et le Royaume-Uni sont des acteurs clés, mettant l’accent sur l’adoption de dispositifs intelligents et automatisés pour améliorer l’efficacité et la sécurité.
• La région Asie-Pacifique connaît une croissance rapide du marché des dispositifs d'administration de vaccins, stimulée par l'expansion des infrastructures de santé et des programmes de vaccination à grande échelle dans des pays comme la Chine, l'Inde et le Japon. L'adoption de dispositifs avancés, notamment les seringues autobloquantes et les injecteurs sans aiguille, augmente en raison de vastes initiatives de santé publique.
• La région du Moyen-Orient et de l’Afrique adopte progressivement des systèmes de distribution de vaccins traditionnels et innovants pour améliorer la prestation de soins de santé et étendre la couverture vaccinale.

Principaux acteurs du marché mondial des dispositifs d'administration de vaccins

• BD (États-Unis)
• INOVIO Pharmaceuticals (États-Unis)
• Vaxxas (États-Unis)
• Gerresheimer AG (Allemagne)
• Corium Inc. (États-Unis)
• Enesi (États-Unis)
• Micropoint Technologies (Singapour)
• SCHOTT AG (Allemagne)
• 3M (États-Unis)
• Mystic Pharmaceuticals (États-Unis)
• NanoPass Rev (États-Unis)
• Terumo Europe NV (Belgique)
• D'Antonio Consultants International, Inc. (États-Unis)
• West Pharmaceutical Services, Inc. (États-Unis)
• Mylan NV (États-Unis)
• Technologies Médicales Internationales Inc. (Canada)
• Antares Pharma (États-Unis)

Développements récents du marché mondial des dispositifs d'administration de vaccins

• En décembre 2023, la FDA américaine a temporairement suspendu une étude de phase III du vaccin contre le cancer à ADN VGX-3100 proposé par Inovio en raison de préoccupations concernant son mécanisme d'administration. La Food and Drug Administration (FDA) a demandé des preuves pour justifier la durée de conservation des pièces jetables du dispositif Cellectra 5pSp utilisé pour administrer le VGX-3100.
• En novembre 2023, l'UNICEF et Gavi fournissent 3,2 millions de dollars en équipement informatique et de gestion des déchets au ministère de la Santé pour aider à stimuler les programmes de vaccination de l'Ouzbékistan.
• En mars 2022, dans le cadre d’un accord d’urgence avec l’UNICEF, le gouvernement japonais a distribué des équipements de chaîne du froid pour renforcer la capacité à long terme du système de santé zambien, notamment la distribution de vaccins vitaux contre la COVID-19.
• En novembre 2023, Vaxxas annonce et rend public le succès de l'essai clinique de phase I du vaccin contre la rougeole et la rubéole administré à l'aide de son patch cutané exclusif à base de microarray haute densité ; projets d'essai de phase I/II en Gambie, en Afrique.

SKU-55561